Genetic Characterization of Natural Variants of Vpu from HIV-1 Infected Individuals from Northern India and Their Impact on Virus Release and Cell Death
Background Genetic studies reveal that vpu is one of the most variable regions in HIV-1 genome. Functional studies have been carried out mostly with Vpu derived from laboratory adapted subtype B pNL 4-3 virus. The rationale of this study was to characterize genetic variations that are present in the vpu gene from HIV-1 infected individuals from North-India (Punjab/Haryana) and determine their functional relevance. Methods Functionally intact vpu gene variants were PCR amplified from genomic DNA of HIV-1 infected individuals. These variants were then subjected to genetic analysis and unique representative variants were cloned under CMV promoter containing expression vector as well as into pNL 4-3 HIV-1 virus for intracellular expression studies. These variants were characterized with respect to their ability to promote virus release as well as cell death. Results Based on phylogenetic analysis and extensive polymorphisms with respect to consensus Vpu B and C, we were able to arbitrarily assign variants into two major groups (B and C). The group B variants always showed significantly higher virus release activity and exhibited moderate levels of cell death. On the other hand, group C variants displayed lower virus release activity but greater cell death potential. Interestingly, Vpu variants with a natural S61A mutation showed greater intracellular stability. These variants also exhibited significant reduction in their intracellular ubiquitination and caused greater virus release. Another group C variant that possessed a non-functional β-TrcP binding motif due to two critical serine residues (S52 and S56) being substituted with isoleucine residues, showed reduced virus release activity but modest cytotoxic activity. Conclusions The natural variations exhibited by our Vpu variants involve extensive polymorphism characterized by substitution and deletions that contribute toward positive selection. We identified two major groups and an extremely rare β-TrcP binding motif mutant that show widely varying biological activities with potential implications for conferring subtype-specific pathogenesis.
References
[1]
Cummins NW, Badley AD (2010) Mechanisms of HIV-associated lymphocyte apoptosis: 2010. Cell Death and Disease 1: e99.
[2]
Badley AD, Pilon AA, Landay A, Lynch DH (2000) Mechanisms of HIV-associated lymphocyte apoptosis. Blood 96: 2951–2964.
[3]
Emerman M, Malim MH (1998) HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. Science 280: 1880–1884.
[4]
Malim MH, Emerman M (2008) HIV-1 accessory proteins–ensuring viral survival in a hostile environment. Cell Host Microbe. 3: 388–398.
[5]
Bonhoeffer S, Holmes EC, Nowak MA (1995) Causes of HIV diversity. Nature. 13: 125.
[6]
Wain-Hobson S (1993) The fastest genome evolution ever described: HIV variation in situ. Curr. Opin. Genet. Dev. 3: 878–883.
[7]
Ji J, Loeb LA (1994) Fidelity of HIV-1 reverse transcriptase copying a hypervariable region of the HIV-1 env gene. Virology 199: 323–30.
[8]
Yusim K, Kesmir C, Gaschen B, Addo MM, Altfeld M, et al. (2002) Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation. J Virol. 76: 8757–68.
[9]
Strebel K, Klimkait T, Martin MA (1988) A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science 241: 1221–1223.
[10]
Cohen EA, Terwilliger EF, Sodroski JG, Haseltine WA (1988) Identification of a protein encoded by the vpu gene of HIV-1. Nature 334: 532–534.
[11]
Matsuda Z, Chou MJ, Matsuda M, Huang JH, Chen YM, et al. (1988) Human immunodeficiency virus type 1 has an additional coding sequence in the central region of the genome. Proc Natl Acad Sci U S A 85: 6968–6972.
[12]
Yang SJ, Lopez LA, Exline CM, Haworth KG, Cannon PM (2011) Lack of adaptation to human tetherin in HIV-1 group O and P. Retrovirology. 8: 78.
[13]
Douglas JL, Viswanathan K, McCarroll MN, Gustin JK, Früh K, et al. (2009) Vpu Directs the Degradation of the Human Immunodeficiency Virus Restriction Factor BST-2/Tetherin via a βTrCP-Dependent Mechanism. J Virol. 83: 7931–7947.
[14]
Margottin F, Bour SP, Durand H, Selig L, Benichou S, et al. (1998) A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol Cell. 1: 565–574.
[15]
Schubert U, Henklein P, Boldyreff B, Wingender E, Strebel K, et al. (1994) The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif. J Mol Biol. 236: 16–25.
[16]
Akari H, Bour S, Kao S, Adachi A, Strebel K (2001) The Human Immunodeficiency Virus Type 1 Accessory Protein Vpu Induces Apoptosis by Suppressing the Nuclear Factor {kappa}β-dependent Expression of Antiapoptotic Factors. J Exp Med. 194: 1299–1311.
[17]
Verma S, Ali A, Arora S, Banerjea AC (2011) Inhibition of β-TrcP–dependent ubiquitination of p53 by HIV-1 Vpu promotes p53–mediated apoptosis in human T cells. Blood. 117: 6600–6607.
[18]
Schubert U, Bour S, Ferrer-Montiel AV, Montal M, Maldarell F, et al. (1996) The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J Virol. 70: 809–819.
[19]
Pacyniak E, Gomez ML, Gomez LM, Mulcahy ER, Jackson M, et al. (2005) Identification of a region within the cytoplasmic domain of the subtype B Vpu protein of human immunodeficiency virus type 1 (HIV-1) that is responsible for retention in the golgi complex and its absence in the Vpu protein from a subtype C HIV-1. AIDS Res Hum Retroviruses. 21: 379–394.
[20]
Hussain A, Das SR, Tanwar C, Jameel S (2007) Oligomerization of the human immunodeficiency virus type 1 (HIV-1) Vpu protein – a genetic, biochemical and biophysical analysis. Virol J. 4: 81.
[21]
Lee CN, Wang WK, Fan WS, Twu SJ, Chen SC, et al. (2000) Determination of Human Immunodeficiency Virus Type 1 Subtypes in Taiwan by vpu Gene Analysis. J. Clin. Microbiol. 38: 2468.
[22]
Jens T, Florette S, Treurnicht K, Zeier M, Engelbrecht S, et al. (2001) Characterization and Phylogenetic Analysis of South African HIV-1 Subtype C Accessory Gene. Aids Research and Human Retroviruses. 8: 775–781.
[23]
Hill MS, Ruiz A, Pacyniak E, Pinson DM, Culley N, et al. (2008) Modulation of the severe CD4+ T-cell loss caused by a pathogenic simian-human immunodeficiency virus by replacement of the subtype B vpu with the vpu from a subtype C HIV-1 clinical isolate. Virology. 371: 86–97.
[24]
Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, et al. (1986) Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol. 59: 284–291.
[25]
Estrabaud E, Rouzic EL, Lopez-Vergès S, Morel M, Bela？douni N, et al. (2007) Regulated Degradation of the HIV-1 Vpu Protein through a βTrCP-Independent Pathway Limits the Release of Viral Particles. PLoS Pathogens 7: e104.
[26]
Magadán JG, Bonifacino JS (2012) Transmembrane domain determinants of CD4 Downregulation by HIV-1 Vpu. J Virol. 86: 757–72.
[27]
Skasko M, Wang Y, Tian Y, Tokarev A, Munguia J, et al. (2012) HIV-1 Vpu protein antagonizes innate restriction factor BST-2 via lipid-embedded helix-helix interactions. J Biol Chem. 287: 58–67.
[28]
Lv M, Wang J, Wang X, Zuo T, Zhu Y, et al. (2011) Polarity changes in the transmembrane domain core of HIV-1 Vpu inhibits its anti-tetherin activity. PLoS One 6: e20890.
[29]
Miyagi E, Andrew AJ, Kao S, Strebel K (2009) Vpu enhances HIV-1 virus release in the absence of BST-2 cell surface down-modulation and intracellular depletion. Proc. Natl. Acad. Sci. USA 106: 2868–2873.
[30]
Paul M, Mazumder S, Raja N, Jabbar MA (1998) Mutational Analysis of the Human Immunodeficiency Virus Type 1 Vpu Transmembrane Domain That Promotes the Enhanced Release of Virus-Like Particles from the Plasma Membrane of Mammalian Cells. J. Virol. 72: 1270.
[31]
Bano AS, Sood V, Neogi U, Goel N, Kuttiat VS, et al. (2009) Genetic and functional characterization of human immunodeficiency virus type 1 VprC variants from north India: presence of unique recombinants with mosaic genomes from B, C and D subtypes within the open reading frame of Vpr. J Gen Virol. 90: 2768–2776.
[32]
Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position specific gap penalties and weight matrix choice. Nucleic Acids Res. 22: 4673–4680.
[33]
Saitou N, Nei M (1987) The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol. 4: 406–425.
[34]
Kimura M (1980) A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol. 16: 111–120.
[35]
Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 24: 1596–1599.
[36]
Korber B (2000) HIV Signature and Sequence Variation Analysis. Computational Analysis of HIV Molecular Sequences 4: 55–72.
[37]
De Candia C, Espada C, Duette G, Ghiglione Y, Turk G, et al. (2010) Viral replication is enhanced by an HIV-1 intersubtype recombination-derived Vpu protein. Virol J. 7: 259.
[38]
Kubbutat MH, Ludwig RL, Ashcroft M, Vousden KH (1998) Regulation of Mdm-2 directed degradation by the C terminus of p53. Mol Cell Biol. 18: 5690–5698.
[39]
Cornall A, Sharma L, Solomon A, Gorry PR, Crowe SM (2010) A novel, rapid method to detect infectious HIV-1 from plasma of persons infected with HIV-1. J Virol Methods. 165: 90–96.
